A Study of NKTR-358 (LY3471851) in Participants With Systemic Lupus Erythematosus (SLE)
All edits
Edits on 13 Jan, 2024
Golden AI
Edits made to:
Infobox (+15 properties)
Article (+203 characters)
A Study of NKTR-358 (LY3471851) in Participants With Systemic Lupus Erythematosus (SLE)
Article
Study summary
The main purpose of this study is to evaluate the safety and tolerability of a study drug known as LY3471851 in participants with SLE. The study will last about 79 days for each participant.
Infobox
Is a
NCT Number
Trial Recruitment Size
480
Trial Sponsor
Clinical Trial Start Date
April 18, 2018
0Primary Completion Date
August 29, 2019
0Study Completion Date
August 29, 2019
0Clinical Trial Study Type
Interventional0
Interventional Trial Purpose
Basic Science0
Official Website
Official Name
A Phase 1, Double-blind, Randomized, Placebo-controlled, Ascending Multiple-dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneous NKTR-358 in Patients With Systemic Lupus Erythematosus0
Last Updated
November 18, 2023
0Allocation Type
Randomized0
Intervention Model
Parallel Assignment0
Masking Type
Double0
Find more entities like A Study of NKTR-358 (LY3471851) in Participants With Systemic Lupus Erythematosus (SLE)
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.